Cardiovascular disease - DiabetesontheNet

Using carotid artery intimal thickness to investigate the cardiovascular risk of pioglitazone versus glimepiride

Intensive lipid lowering is beneficial. PROVE IT-TIMI!

Quantifying and addressing the cardiovascular risks of diabetes in South Asian populations

Cardiovascular disease risk modification in abdominally obese people with type 2 diabetes

The endocannabinoid system: Its intervention and subsequent effects on cardiometabolic risk

Optimising the care of patients with type 2 diabetes and cardiovascular disease: Translating evidence-based medicine into practice

The significance of microalbuminuria in clinical practice

A cardiovascular risk algorithm for people not under current management

Managing CV risk in type 2 diabetes: Towards best practice (Part 3: Antihypertensive agents)

Persistent long-term increased risk for stroke in people with diabetes mellitus

At what age do people with diabetes become susceptible to developing cardiovascular disease?

Hyperglycaemia and hypertension increase risk of developing complications in people with type 2 diabetes

Risk of serious cardiovascular treatment-emergent adverse events not increased with tadalafil

Managing CV risk in type 2 diabetes: Towards best practice (Part 2: Oral glucose-lowering agents)

Diabetes lessens the response of LVH to treatment

Lower cardiovascular risk with metformin monotherapy

Non-alcoholic fatty liver disease: Another factor requiring aggressive risk management?

No cardiovascular benefits seen with high-dose vitamin B